SSA
IDXX icon

Schonfeld Strategic Advisors’s Idexx Laboratories IDXX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.43M Buy
+15,003
New +$9.62M 0.06% 341
2025
Q4 		– Sell
-8,291
Closed -$5.3M – 2276
2025
Q3 		$5.3M Buy
8,291
+7,542
+1,007% +$4.58M 0.03% 563
2025
Q2 		$402K Buy
+749
New +$358K ﹤0.01% 1610
2025
Q1 		– Sell
-9,280
Closed -$3.84M – 2332
2024
Q4 		$3.84M Buy
9,280
+5,085
+121% +$2.23M 0.02% 593
2024
Q3 		$2.12M Buy
+4,195
New +$2.04M 0.01% 853
2023
Q4 		– Sell
-8,201
Closed -$3.59M – 2029
2023
Q3 		$3.59M Sell
8,201
-317
-4% -$158K 0.03% 644
2023
Q2 		$4.28M Buy
8,518
+5,652
+197% +$2.71M 0.04% 532
2023
Q1 		$1.43M Buy
+2,866
New +$1.37M 0.01% 797
2022
Q4 		– Sell
-4,932
Closed -$1.61M – 2790
2022
Q3 		$1.61M Sell
4,932
-4,814
-49% -$1.77M 0.01% 977
2022
Q2 		$3.42M Buy
9,746
+8,317
+582% +$3.39M 0.03% 577
2022
Q1 		$782K Buy
+1,429
New +$752K 0.01% 1121
2021
Q2 		– Sell
-8,480
Closed -$4.15M – 2105
2021
Q1 		$4.15M Buy
8,480
+5,680
+203% +$2.85M 0.05% 478
2020
Q4 		$1.4M Buy
+2,800
New +$1.25M 0.02% 699
2020
Q1 		– Sell
-5,468
Closed -$1.43M – 1314
2019
Q4 		$1.43M Buy
+5,468
New +$1.44M 0.03% 409
2019
Q3 		– Sell
-2,300
Closed -$633K – 1121
2019
Q2 		$633K Buy
2,300
+1,000
+77% +$246K 0.02% 570
2019
Q1 		$291K Buy
+1,300
New +$268K 0.01% 841
2018
Q4 		– Sell
-32,200
Closed -$8.04M – 1143
2018
Q3 		$8.04M Sell
32,200
-15,811
-33% -$3.84M 0.36% 65
2018
Q2 		$10.5M Buy
48,011
+26,439
+123% +$5.45M 0.57% 21
2018
Q1 		$4.13M Sell
21,572
-3,469
-14% -$640K 0.31% 94
2017
Q4 		$3.92M Sell
25,041
-10,721
-30% -$1.69M 0.32% 89
2017
Q3 		$5.56M Buy
35,762
+33,664
+1,605% +$5.32M 0.51% 54
2017
Q2 		$339K Buy
+2,098
New +$341K 0.03% 451

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's IDXX Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Idexx Laboratories (IDXX) in Q1 2026: 15,003 shares worth $8.43M. The stake represents 0.06% of the portfolio and ranks #341 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in IDXX as recently as Q3 2025.

Schonfeld Strategic Advisors first reported a position in IDXX in Q2 2017 and has held it in 22 quarters since. The position peaked at $10.5M in Q2 2018. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Schonfeld Strategic Advisors held 15,003 shares of Idexx Laboratories worth $8.43M as of Q1 2026.
  • Idexx Laboratories was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Idexx Laboratories made up 0.06% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #341 holding.
  • Schonfeld Strategic Advisors first reported a position in Idexx Laboratories in Q2 2017 and has held it in 22 quarters since.
  • Schonfeld Strategic Advisors's Idexx Laboratories position peaked at $10.5M in Q2 2018.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.